CST BLOG: Lab Expectations

The official blog of Cell Signaling Technology (CST), where we discuss what to expect from your time at the bench, share tips, tricks, and information.

All Posts

Have you been wondering how to monitor a cell state or cellular response? From a basic research standpoint, signaling pathways are so intertwined that cell readouts are a must-have to fully understand the consequences when, for example, a specific protein is modified or an epigenetic event occurs.

In today’s publishing world, it’s not enough to know that a protein gets phosphorylated when exposed to a known stimulus; you must also know the effect that phosphorylation event has on the behavior of a cell population. From a translational medicine standpoint, knowing how a cell population responds to a potential treatment is critical. This can include, but is not limited to, looking for apoptosis for neurodegenerative diseases, senescence for oncological diseases, and immune responses against viral infections.

 

Key Markers to Monitor Cellular State and Cellular Response

Cell states can be monitored by measuring key markers or readouts that correlate to your process of interest. A particular process can have several readouts that can be used with different methodologies. This gives you the ability to measure multiple key markers to guard against false positives and gives you the flexibility to select the marker, application, and detection method that will work best for your experiment.

For example, there are multiple ways to monitor apoptosis by targeting different hallmarks of cell death and signaling pathways. Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) is a stain that detects fragmented DNA observed in late-stage apoptosis. It is widely used to detect apoptotic cells using flow cytometry, immunohistochemistry, or fluorescent microscopy. Similarly, Annexin V binding to phosphatidylserine (PS) is often used with flow cytometry to monitor early-stage apoptosis when PS flips within the plasma membrane and appears on the cell surface. Finally, caspase-3 activation can be used with western blots, immunohistochemistry, or fluorescent microscopy to monitor caspase-induced apoptosis.

 

Monitoring Cell Senescence

Senescence can also be monitored in several different ways. One common approach is an assay that measures increased activity of β-galactosidase, a hallmark of senescence. Enzyme activity can be quantitatively measured with fluorescence using flow cytometry or a plate-based assay, or imaged using a staining kit.

Cell senescence can also be monitored by detecting the expression senescence markers like p16 INK4A, p21 Waf1/Cip1, and Lamin B1 using western blotting, immunoprecipitation, immunohistochemistry, immunofluorescence, or flow cytometry.

 

Assay Kits and Antibodies for Monitoring Cell State

Cell Signaling Technology has a variety of cellular assay kits and antibody sampler kits that target key markers to help you get started.

 

Cell Proliferation

Proliferation and Apoptosis

Cell Viability

Oxidative State

Cytotoxicity

Apoptosis

Senescence 

 

Andrea Tu, PhD
Andrea Tu, PhD
Andrea Tu, PhD, is a Scientific Marketing Manager at Kallidus Group who geeks out when learning about the latest scientific trends and developments. She received a PhD in Molecular and Cell Biology from the University of California, Berkeley where she studied Smad post-translational modifications in the TGF-β signaling pathway. Over the course of 20 years, Andrea has worked at UC San Diego, the Salk Institute, Stanford, Agilent Technologies, and Bio-Techne in technical roles spanning R&D, sales support, and marketing.

Recent Posts

Cell Preparation Tips for Accurate Flow Cytometry Data

Generating accurate flow cytometry data requires more than just specific and sensitive antibodies validat...
Andrea Tu, PhD Nov 6, 2024

500 Antibodies & Counting: Accelerating Discovery with CST Antibodies Validated for Simple Western Technology

Since 2022, Cell Signaling Technology (CST) and Bio-Techne have been working together to bring best-in-cl...
Chris LaBreck, PhD Oct 23, 2024

Menin-KMT2A Inhibitors: A Promising Approach to Acute Myeloid Leukemia (AML) Treatment

Accounting for about 80% of adult acute leukemias, acute myeloid leukemia (AML) is an aggressive form of ...
Homa Rahnamoun, PhD Oct 16, 2024